Champix (varenicline) — Potential Risk Posed By Long-term Exposure To Nitrosamine Impurity, N-nitrosovarenicline, Exceeding Acceptable Intake Limi
Champix Recall Summary Champix (varenicline), a prescription medication used to help people quit smoking, is being recalled across Canada because some batches contain higher-than-acceptable levels of a potentially harmful impurity called N-nitrosovarenicline. This impurity may pose a health risk if people take the medication long-term with levels exceeding what health authorities consider safe. The recall affects Champix products distributed nationwide in Canada.
- Reason
- Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2021-06-30
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/b70f43d0-5172-409a-a45a-d7cedf07ab20